Fresenius SE & Co. KGaA / Key word(s): Quarter Results 04.05.2011 07:08 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Excellent start into 2011 â Fresenius raises 2011 sales and earnings outlook Group sales increased by 9% (7% in constant currency) to EUR3,962 million (Q1 2010: EUR3,643 million). Organic sales growth was 6%. Acquisitions contributed 1%, currency translation effects a further 2%. Group EBIT increased by 15% (13% in constant currency) to EUR575 million (Q1 2010: EUR501 million). The EBIT margin increased to 14.5% (Q1 2010: 13.8%). Group net income* increased by 43% (39% in constant currency) to EUR170 million (Q1 2010: EUR119 million). Earnings per ordinary share increased by 41% to EUR1.05. Group net income** (including special items) reached EUR128 million or EUR0.79 per ordinary share. Fresenius Group raises its sales and earnings guidance for 2011. The company now expects sales growth of 7% to 8% and net income growth* of 12% to 16%, both in constant currency. Previously, the company expected sales growth of >=7% and net income growth* of 8% to 12%, both in constant currency. * Net income attributable to Fresenius SE & Co. KGaA; adjusted for the effects of mark-to-market accounting of the Mandatory Exchangeable Bonds (MEB) and the Contingent Value Rights (CVR) related to the acquisition of APP Pharmaceuticals. Both are non-cash items. ** Net income attributable to Fresenius SE & Co. KGaA (Financial statements according to U.S. GAAP) Fresenius SE & Co. KGaA, represented by Fresenius Management SE, Board of Management Bad Homburg v.d.H., May 4, 2011 End of note 04.05.2011 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Fresenius SE & Co. KGaA Else-Kröner-StraÃe 1 61352 Bad Homburg v.d.H. Deutschland Phone: +49 (0)6172 608-2485 Fax: +49 (0)6172 608-2488 E-mail: ir-fre@fresenius.com Internet: www.fresenius.com ISIN: DE0005785604 WKN: 578560 Indices: DAX Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Hamburg, Hannover, Stuttgart; Terminbörse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Fresenius SE & Co. KGaA: Excellent start into 2011 â Fresenius raises 2011 sales and earnings outlook
| Source: EQS Group AG